久久亚洲国产成人影院-久久亚洲国产的中文-久久亚洲国产高清-久久亚洲国产精品-亚洲图片偷拍自拍-亚洲图色视频

Global EditionASIA 中文雙語Fran?ais
Opinion
Home / Opinion / Opinion Line

No tariffs on targeted cancer drugs will reduce the price pain for patients

China Daily | Updated: 2018-03-22 07:07
Share
Share - WeChat

Premier Li Keqiang promises zero tariff rates for targeted cancer drugs at a news conference after the two sessions in Beijing on Tuesday. Thepaper.cn comments:

It is estimated more than 2 million people die of cancer in China each year. If there are zero tariffs, the retail price of the imported lifesaving drugs used in targeted cancer therapies will drop markedly. Their high prices have resulted in a large number of cancer patients exhausting their savings to extend their lives for a short time.

Some imported targeted cancer therapies can cost a patient as much as 10,000 yuan ($1,579) a dose as they are not covered by the medical insurance system. The high prices mean many patients have to give up their treatment.

More and more patients have turned to buying medicines from India through various channels as the prices are much lower, or to generic drugs that are lower in both price and efficiency. They then take the medicines at home without professional instruction and monitoring, further risking their health.

Aside from the tariffs, the high retail price of imported drugs in China is also pushed up by agents' fees, value-added tax, and high basic prices, which stem from the super-national treatment that some foreign medicines have been enjoying in the drug procurement of public hospitals, even if some of their patent protections have expired.

The pledge to end the tariffs on targeted cancer therapies indicates that the government recognizes they are special goods concerning people's welfare. But even without the tariffs, there still remains considerable room to squeeze the profit links between customs and patients to further bring down the prices of the drugs.

That the government has to open doors to imported drugs to save people's lives should also ring alarm bells for domestic pharmaceutical companies, especially the State-owned ones, as they have no reasons to sit idle, and are obliged to strengthen their research into these badly needed medicines and try their best to acquire the ability of producing them as early as possible.

Most Viewed in 24 Hours
Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
主站蜘蛛池模板: 女人扒开双腿让男人捅 | 日韩一级欧美一级 | 免费公开视频人人人人人人人 | 久久99国产精一区二区三区 | 在线综合亚洲欧美自拍 | 伊在人亚洲香蕉精品区 | 久草视频在线免费 | 国产在线观看网址你懂得 | 国产一二三区在线 | 成人影院久久久久久影院 | 久久99热只有视精品6国产 | 久草免费在线观看 | 最近中文字幕精彩视频 | 精品视频在线观看一区二区三区 | 国产网站免费视频 | 成人做爰视频www网站 | 久久亚洲国产最新网站 | 国产片18在线观看 | 九九免费精品视频 | 亚洲男女视频 | 国内成人自拍 | 国产成人高清视频在线观看免费97 | 久草热视频 | 国产精品永久免费自在线观看 | 亚洲一区日韩一区欧美一区a | 国产一级视频久久 | 一级毛毛片毛片毛片毛片在线看 | 日本高清视频一区二区 | 成年人在线观看视频网站 | 深夜福利亚洲 | 国产女王女m视频vk 国产女王丨vk | 国产伦精一区二区三区视频 | 欧美丝袜xxxxx在线播放 | 香蕉超级碰碰碰97视频在线观看 | 亚洲国产成人精品久久 | 亚洲精品久久久久久久久久久网站 | 欧美精品国产精品 | 国产成人免费视频 | 黄视频在线免费 | 亚洲人成综合网站在线 | 日本国产欧美 |